New-onset diabetes after transplantation: A review of recent literature

Current Opinion in Organ Transplantation

Volumn 14, Issue 4, 2009, Pages 375-379

  Balla, Ashfaq ^a,c   Chobanian, Michael ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c METHODIST UNIVERSITY HOSPITAL   (United States)

Author keywords

Cyclosporine; Diabetes; Hepatitis C; Immunosuppression; New onset diabetes after transplantation; Posttransplant diabetes; Sirolimus; Tacrolimus; Transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

CARDIOVASCULAR RISK; DIABETES MELLITUS; GENETIC POLYMORPHISM; HEPATITIS C; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; ORAL GLUCOSE TOLERANCE TEST; ORGAN TRANSPLANTATION; REVIEW;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EARLY DIAGNOSIS; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; RISK FACTORS;

EID: 68849123873     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832dbb98     Document Type: Review

References (28)

1. Grundy S, Howard B, Smith S Jr, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of American heart Association. Circulation 2002; 105:2231. (Pubitemid 34517172)
2. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 2003; 75:S3.
3. Gavin JR, Alberti KG, Davidson MB, et al. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1):S5.
4. Sulanc E, Lane J, Puumala SE, et al. New-onset diabetes after kidney transplantation: an application of 2003 international guidelines. Transplantation 2005; 80:945.
5. Pham PT, Pham PC. Assessing the risk of posttransplantation diabetes mellitus with an oral glucose tolerance test. Nat Clin Prac Nephrol 2008 4:600-601. The article describes the value of testing other than routine blood sugar measurements on the prediction of NODAT.
6. Sharif A, Moore RH, Baboolal K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon. Transplantation 2006; 82:1667. (Pubitemid 46035649)
7. Kuypers D, Claes K, Bammens B, et al. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of posttransplant diabetes mellitus (PTDM). Nephrol Dialysis Transplant 2008; 23:2033. The article describes the value of testing other than routine blood sugar measurements on the prediction of NODAT. (Pubitemid 351768147)
8. Montori V, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002; 5:583.
9. Elmagd MM, Bakr M, Ametwally AH, et al. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant. Exp Clin Transplant 2008; 6:42-47. (Pubitemid 351983975)
10. Kamar N, Mariat C, DelaHousse M, et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant 2007; 22:1986. (Pubitemid 47244771)
11. Chan HW, Cheung CY, Liu YL, et al. Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: a single-centre study. Nephrol Dial Transplant 2008; 23:3337.
12. Ollech J, Kramer M, Peled N, et al. Posttransplant diabetes mellitus in lung transplant recipients: incidence and risk factors. Eur J Cardiothorac Surg 2008; 33:844. This article describes the incidence of new-onset diabetes after lung transplantation.
13. Rodrigo E, Fernandez-Fresnedo G, Valero R, et al. New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 2006; 17:S291. (Pubitemid 44865264)
14. Fabrizi F, Messa P, Martin P, et al. Hepatitis C virus infection and posttransplant diabetes mellitus among renal transplant patients: a meta-analysis. Int J Artif Organs 2008; 31:675. This article is a meta-analysis of published literature regarding the association of posttransplant diabetes and hepatitis C.
15. Saboo D, Shah PR, Goplani KR, et al. Posttransplant diabetes mellitus: a single-center study. Transplant Proc 2008; 40:1111. (Pubitemid 351802234)
16. Ma Y, Yan WW. Chronic hepatitis C virus infection and postliver transplantation diabetes mellitus. World J Gastroenterol 2005; 11:6085. (Pubitemid 43085046)
17. Zhang X, Chen XM, Gao HN, et al. Association of post transplantation diabetes mellitus to active human cytomegalovirus infection and preoperative hepatitis B infection: analysis of 75 cases. Zhonghua Yi Xue Za Zhi 2008; 88 (29):2053.
18. Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004; 4:583. (Pubitemid 38523581)
19. Vincenti F, Friman S, El-Shahawy M, et al. Results of an international randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus (DIRECT). Am J Transplant 2007; 7:1506. (Pubitemid 46776239)
20. Webster A, Woodroffe R, Taylor R, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomized trial data. BMJ 2005; 10:1136. (Pubitemid 41442360)
21. Plaumann S, Blume R, Borchers S, et al. Activation of the dual-leucine-zipperbearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A. Mol Pharmacol 2008; 73:652.
22. Araki M, Flechner S, Ismail HR, et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 2006; 81:335-341. (Pubitemid 43255716)
23. Johnston O, Rose CL, Webster AC, et al. Sirolimus is associated with newonset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19:1255. This article describes the incidence of new-onset diabetes after sirolimus use along with other immunosuppression regimens.
24. Kang ES, Kim MS, Kim YS, et al. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients. Diabetes 2008; 57:1043. The article suggests a correlation between NODAT and genetic polymorphisms seen in diabetes mellitus.
25. Kang ES, Kim MS, Kim YS, et al. A variant of the transcription factor 7-like 2(TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Diabetes Care 2008; 31:63. The article suggests a correlation between NODAT and genetic polymorphisms seen in diabetes mellitus.
26. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset posttransplantation diabetes mellitus on major cardiac events. Kidney Int 2006; 69:588. (Pubitemid 43164454)
27. Duclox D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005; 79:438. (Pubitemid 40280176)
28. Cole EH, Johnston O, Rose C, et al. Impact of acute rejection and new-onset diabetes on long-termtransplant graft and patient survival. CJASN2008; 3:814. This article describes how acute rejection and new-onset diabetes affect graft and patient survival.